Risk factors for total joint arthroplasty infection in patients receiving tumor necrosis factor α-blockers: a case-control study. - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Arthritis Research and Therapy Année : 2010

Risk factors for total joint arthroplasty infection in patients receiving tumor necrosis factor α-blockers: a case-control study.

Laure Gossec
Xavier Mariette
Marie-Hélène Guyot
  • Fonction : Auteur
  • PersonId : 918907
Jean-Marie Berthelot
  • Fonction : Auteur
  • PersonId : 918401
Daniel Wendling
Pierre Dellamonica
  • Fonction : Auteur
  • PersonId : 918909
Maxime Dougados

Résumé

INTRODUCTION: The objective of this study was to assess natural microbial agents, history and risk factors for total joint arthroplasty (TJA) infections in patients receiving tumor necrosis factor (TNF)α-blockers, through the French RATIO registry and a case-control study. METHODS: Cases were TJA infections during TNFα-blocker treatments. Each case was compared to two controls (with TJA and TNFα-blocker therapy, but without TJA infection) matched on age (±15 years), TJA localization, type of rheumatic disorder and disease duration (±15 years). Statistical analyses included univariate and multivariate analyses with conditional logistic regression. RESULTS: In the 20 cases (18 rheumatoid arthritis), TJA infection concerned principally the knee (n = 12, 60%) and the hip (n = 5, 25%). Staphylococcus was the more frequent microorganism involved (n = 15, 75%). Four patients (20%) were hospitalized in an intensive care unit and two died from infection. Eight cases (40%) versus 5 controls (13%) had undergone primary TJA or TJA revision for the joint subsequently infected during the last year (P = 0.03). Of these procedures, 5 cases versus 1 control were performed without withdrawing TNFα-blockers (P = 0.08). In multivariate analysis, predictors of infection were primary TJA or TJA revision for the joint subsequently infected within the last year (odds ratio, OR = 88.3; 95%CI 1.1-7,071.6; P = 0.04) and increased daily steroid intake (OR = 5.0 per 5 mg/d increase; 1.1-21.6; P = 0.03). Case-control comparisons showed similar distribution between TNFα-blockers (P = 0.70). CONCLUSIONS: In patients receiving TNFα-blockers, TJA infection is rare but potentially severe. Important risk factors are primary TJA or TJA revision within the last year, particularly when TNFα-blockers are not interrupted before surgery, and the daily steroid intake.
Fichier principal
Vignette du fichier
ar3087.pdf (218.8 Ko) Télécharger le fichier
ar3087.xml (85.88 Ko) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte
Format Autre
Loading...

Dates et versions

inserm-00663730 , version 1 (27-01-2012)

Identifiants

Citer

Mélanie Gilson, Laure Gossec, Xavier Mariette, Dalenda Gherissi, Marie-Hélène Guyot, et al.. Risk factors for total joint arthroplasty infection in patients receiving tumor necrosis factor α-blockers: a case-control study.. Arthritis Research and Therapy, 2010, 12 (4), pp.R145. ⟨10.1186/ar3087⟩. ⟨inserm-00663730⟩
135 Consultations
231 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More